Effect of endovascular closure of the patent foramen ovale on the severity of symptoms of migraine with aura: a clinical study

Aim. To study the effect of endovascular closure of patent foramen ovale (PFO) on the severity of symptoms of migraine attacks in patients with migraine with a history of aura.Materials and Methods. We analyzed the data of 74 patients with migraine with a history of aura who underwent endovascular closure of the PFO for the period from 2018 to 2022 at the E.I. Chazov National Medical Research Center of Cardiology. All patients underwent examinations that complied with clinical recommendations. The presence of a history of migraine with aura was determined through a patient interview, previous hospital history, and was confirmed by a neurologist. The severity of migraine symptoms was assessed using the MIDAS (Migraine Disability Assessment) scale before occluder implantation and after 36,9 [22,7; 50,8] months the intervention as part of a telephone contact.Results. 49 patients before the intervention had pain syndrome assessed on the MIDAS scale